Lee un libro PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) de Valentina Ambrosini,Stefano Fanti Ebooks, PDF, ePub
Descargar PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) de Valentina Ambrosini,Stefano Fanti libros ebooks, PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) Pdf descargar
PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) de Valentina Ambrosini,Stefano Fanti
Descripción - Críticas “This volume provides a succinct summary of the current status of neuroendocrine malignancy, with a particular focus on PETCT imaging techniques. … The book is likely to be of most interest to clinicians involved in the management of this diverse patient group that includes oncologists, nurses, pathologists, surgeons, radiographers/technologists, radiologists and nuclear medicine physicians. An ideal use is as a quick reference guide both in preparation for and at multidisciplinary meetings.” (Dr. Andy Scarsbrook, RAD Magazine, January, 2017)“The book is mainly directed to all clinicians interested in the role of nuclear medicine in patients with NETs. Residents and practitioners in nuclear medicine and radiology may also find this book interesting and useful for improving their understanding of the potential of nuclear medicine in patients affected with these tumours and then for explaining this to their referrers.” (Manuela Amato and Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, 2017)“The intended audience includes anyone involved in the multidisciplinary approach to diagnosis and management of patients with neuroendocrine tumors. This includes nuclear medicine physicians, radiologists, technologists, and pathologists, as well as clinical specialists such as oncologists, endocrinologists, and surgeons. … This is a quick read, but it does not fall short in providing a concise, up-to-date overview of the utility of nuclear medicine, particularly PET/CT, for imaging NETs.” (Daniel Thut, Doody's Book Reviews, August, 2016) Reseña del editor This pocket book provides up-to-date descriptions of the most relevant features of neuroendocrine tumors (NETs) and the imaging modalities currently available to assist specialists (clinicians, pathologists, radiologists, nuclear medicine physicians) in selecting optimal patient management based on interdisciplinary collaboration. As the title indicates, the focus is particularly on PET/CT, with coverage of basic principles, the available radiopharmaceuticals, indications, typical and atypical appearances, normal variants and artifacts, advantages, limitations, and pitfalls. In addition, succinct information is provided on the use of other imaging modalities, including SPECT, CT, and MRI, and on pathology and treatment options. Imaging teaching cases are presented, and key points are highlighted throughout. The book is published as part of a series on hybrid imaging that is specifically aimed at referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings. Contraportada This pocket book provides up-to-date descriptions of the most relevant features of neuroendocrine tumors (NETs) and the imaging modalities currently available to assist specialists (clinicians, pathologists, radiologists, nuclear medicine physicians) in selecting optimal patient management based on interdisciplinary collaboration. As the title indicates, the focus is particularly on PET/CT, with coverage of basic principles, the available radiopharmaceuticals, indications, typical and atypical appearances, normal variants and artifacts, advantages, limitations, and pitfalls. In addition, succinct information is provided on the use of other imaging modalities, including SPECT, CT, and MRI, and on pathology and treatment options. Imaging teaching cases are presented, and key points are highlighted throughout. The book is published as part of a series on hybrid imaging that is specifically aimed at referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings. Biografía del autor Valentina Ambrosini is Associate Professor in Nuclear Medicine (sector MED-36, Diagnostic Imaging) at the University of Bologna. Full-time employed Nuclear Medicine Physician at the PET Center, Nuclear Medicine Unit, S.Orsola-Malpighi University Hospital, Bologna, Italy. She received her medical degree and her Ph.D at the University of Bologna. She was trained and became certified specialist in both in Nuclear Medicine and Respiratory Medicine at the University of Bologna. Initially devoted to small animal imaging with PET, her interests were later focused on clinical PET/CT imaging, with both FDG and non-FDG tracers. She performed many novel investigations on PET/CT imaging with FDG and non-FDG tracers, whose results were published in peer reviewed international journals. She teaches Nuclear Medicine at Medical School and in specialty schools of the University of Bologna. Stefano Fanti is Associate Professor in Nuclear Medicine (sector MED-36, Diagnostic Imaging) at the University of Bologna. Director of the Nuclear Medicine Unit of the S.Orsola-Malpighi University Hospital, Bologna, Italy. Director of the School of Specialty in Nuclear Medicine of the University of Bologna. He received his medical degree at the University of Bologna. He was trained and became certified specialist in Nuclear Medicine at the University of Bologna. He participated as referent physician to the site planning and start up (2002) of the PET center of the S.Orsola-Malpighi University Hospital that, under his supervision and leadership, is now performing more 10000 exams per year and has become one of the most active in Europe. His interest are focused on PET/CT imaging with both FDG and non-FDG tracers. He has conducted many novel investigations with results published in peer reviewed international journals. He has courses at Medical School (University of Bologna) on Nuclear Medicine, and in specialty schools of the University of Bologna.
Detalles del Libro
- Name: PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging)
- Autor: Valentina Ambrosini,Stefano Fanti
- Categoria: Libros,Libros universitarios y de estudios superiores,Medicina y ciencias de la salud
- Tamaño del archivo: 10 MB
- Tipos de archivo: PDF Document
- Descargada: 435 times
- Idioma: Español
- Archivos de estado: AVAILABLE
Descargar PDF PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) de Valentina Ambrosini,Stefano Fanti PDF [ePub Mobi] Gratis
PET/CT in Neuroendocrine Tumors / Springer for Research ~ This pocket book provides up-to-date descriptions of the most relevant features of neuroendocrine tumors (NETs) and the imaging modalities currently available to assist specialists (clinicians, pathologists, radiologists, nuclear medicine physicians) in selecting optimal patient management based on interdisciplinary collaboration.
Imaging in neuroendocrine tumors: an update for the clinician ~ Neuroendocrine tumors (NETs) arise from the diffuse neuroendocrine system, which is comprised of 17 different cell types that reside in skin, lung, the hepatobiliary system, the urogenital tract, thyroid and the gastrointestinal tract [].Though these tumors can arise in any of the aforementioned tissues, the most common primary sites are the lung, rectum and small bowel [].
Types of PET/CT Scans for Neuroendocrine Tumors ~ Your doctor may order imaging tests to diagnose or monitor neuroendocrine tumors. Learn about the newest PET/CT scan using Gallium-68 (Ga-68).
PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to ~ PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) 1st ed. 2016 Edition, Kindle Edition by Valentina Ambrosini (Editor), Stefano Fanti (Editor) Format: Kindle Edition
PET and PET/CT Imaging of Neuroendocrine Tumors ~ PET and PET/CT Imaging of Neuroendocrine Tumors Richard P. Baum Vikas Prasad Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms that are characterized by their endocrine metabolism and histology pattern. Several names such as carcinoid tumor, gastroenteropancreatic (GEP) tumor, islet cell tumor, neuroendocrine tumor, neuroendocrine carcinoma, and others have been suggested to .
PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to ~ PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging): 9783319292021: Medicine & Health Science Books @
PET/CT in Neuroendocrine Tumors / Valentina Ambrosini ~ PET/CT in Neuroendocrine Tumors. Editors: Ambrosini, Valentina, Fanti, Stefano (Eds.) . The book is published as part of a series on hybrid imaging that is specifically aimed at referring clinicians, nuclear medicine/radiology physicians, . Radionuclide Imaging (SPECT) Pages 25-32.
PET and PET–CT in Neuroendocrine Tumors / SpringerLink ~ Becherer A, Szabo M, Karanikas G et al. (2004) Imaging of advanced neuroendocrine tumors with 18 F-FDOPA-PET. J Nucl Med 45:1161–1167 PubMed Google Scholar Belhocine T, Foidart J, Rigo P et al. (2002) Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.
PET/CT in Neuroendocrine Tumors [Repost] / AvaxHome ~ PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) by Valentina Ambrosini, Stefano Fanti English / May 6, 2016 / ISBN: 3319292021 / 92 pages / PDF / 5.25 Mb
PET/CT in Neuroendocrine Tumors - Onkologi - häftad ~ Pris: 766 kr. häftad, 2016. Skickas om 3 vardagar. Köp boken PET/CT in Neuroendocrine Tumors (ISBN 9783319292021) hos Adlibris. Fri frakt. Alltid bra priser och snabb leverans. / Adlibris
[PET-CT for neuroendocrine tumors and nuclear medicine ~ Neuroendocrine tumors (NET) are defined by biochemical characteristics and structures which can be specifically addressed by radioligands for diagnostic imaging as well as radionuclide therapy in nuclear medicine.
PET/CT in Neuroendocrine Tumors - ScienceDirect ~ Neuroendocrine tumors (NETs) are a heterogeneous group of slow-growing rare neoplasms characterized by their endocrine metabolism and histology pattern, occurring in 1 to 4 per 100,000 people per year,1, 2 mostly represented by carcinoid lesions. These tumors originate from pluripotent stem cells or differentiated neuroendocrine cells. 3 Histologically, NETs can be classified on the basis of .
Lab and Imaging Tests for Neuroendocrine Tumors - WebMD ~ Neuroendocrine tumors (NETs) look and act differently than a lot of other tumors, which can make them harder to spot. Your doctor may ask you to take several different tests that can help him make .
Neuroendocrine Tumor Recurrence: Diagnosis with 68Ga ~ Introduction. Neuroendocrine tumors (NETs) are rare malignancies of a heterogeneous biologic nature. Their incidence has been increasing over the past decades, and improvements in diagnosis, including imaging as an essential part, are such that these tumors are increasingly diagnosed at a localized stage (), which enables potentially curative resection in many patients.
PET/CT For Neuroendocrine - Cedars-Sinai ~ PET/CT for Neuroendocrine - What to Expect For patients with neuroendocrine cancers, accurate diagnosis and tracking of tumors has long been very difficult. Fortunately, in June 2016, the U.S. Food and Drug Administration approved a new pharmaceutical that, when used with positron emission tomography (PET), makes these rare tumors visible on medical images.
What to Expect During A PET/CT Scan For Neuroendocrine Tumors ~ The imaging center at PET/CT Mumbai offers combined PET and CT (computed tomography) imaging tests for neuroendocrine tumors. The PET scan highlights the tumors and the CT scan provides your body’s detailed view. The PET and CT images are then combined into one with the help of a computer.
PET/CT captures hidden source of neuroendocrine cancer ~ PET/CT captures hidden source of neuroendocrine cancer The origin of cancer is often obscured by metastases – tumors that have already spread to other tissues. This is especially the case for neuroendocrine tumors (NETs), a malignancy of nerve cells scattered throughout various organ systems that are sensitive to the signaling of neurotransmitters and hormones.
Una nueva modalidad diagnóstica para la detección de ~ We report a 74-year-old maie with liver metastases from a neuroendocrine tumor (NET) of unknown origin. Conventionai imaging studies with ultrasound, computed tomography coionoscopy and Positron emission tomography-computed tomography (PET/CT) with 18 Flúor odeoxyglucose did not identify the site of orígin of the primary tumor. The patient was submitted for a PET/CT sean with a new .
Tumores de tipo neuroendocrino - Grupo Scanner Vizcaya ~ Los tumores del tipo neuroendocrino, nacen en las células neuroendocrinas que producen hormonas y se localizan dispersas por todo el cuerpo humano. No son habituales, pero la prevalencia es importante al tratarse de tumores de lento desarrollo y larga supervivencia.
Imaging of Advanced Neuroendocrine Tumors with 18F-FDOPA PET ~ Abstract. Nuclear medicine plays an important role in the imaging of neuroendocrine tumors (NETs). Somatostatin receptor scintigraphy (SRS) with 111 In-labeled somatostatin receptor analogs is a standard procedure for the detection and staging of NET. Based on the ability of NETs to store biogenic amines, this study evaluated whether 6-18 F-fluoro-l-DOPA (18 F-FDOPA) is a suitable PET tracer .
Guideline for PET/CT imaging of neuroendocrine neoplasms ~ Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using 68Ga-DOTA-conjugated .
Neuroendocrine Tumors in 2016 - LinkedIn SlideShare ~ Neuroendocrine Tumors in 2016 1. NEUROENDOCRINE TUMORS: Mohamed Abdulla M.D. Prof. of Clinical Oncology Cairo University Asyut Clinical Oncology Annual Conference NOVARTIS Symposium 23/02/2016 “Capture a MACRO Portrait” 2. Disclosures: • Amgen • Merck Serono • Janssen Cilag • Astra Zeneca • Pfizer • Astellas.
Neuroendocrine tumor staging with Gallium-68 positron ~ Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68) Ga-DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging. 2010;37:67-77. [ Links ] 5. Srirajaskanthan R, Kayani I, Quigley AM. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111 In- DTPA-octreotide scintigraphy.
Integrated PET/CT of Pulmonary Neuroendocrine Tumors ~ Between May 2003 and February 2005, 37 consecutively enrolled patients (33 men and four women; mean age, 60 years) with histopathologically proven pulmonary neuroendocrine tumors underwent 18 F-FDG PET/CT after enhanced standalone CT.
PET/CT Imaging of Angiogenesis in Patients With ~ PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Post a Comment for "Lee un libro PET/CT in Neuroendocrine Tumors (Clinicians’ Guides to Radionuclide Hybrid Imaging) de Valentina Ambrosini,Stefano Fanti Ebooks, PDF, ePub"